Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 28, 2024; 30(8): 863-880
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.863
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.863
Item, mean (SD) | Sarcopenia | P value | Myosteatosis | P value | ||
Yes (n = 32) | No (n = 83) | Yes (n = 32) | No (n = 83) | |||
ALT (U/L) | 20.31 (16.87) | 22.89 (21.41) | 0.404 | 20.07 (15.82) | 22.98 (21.70) | 0.660 |
AST (U/L) | 27.41 (23.12) | 25.99 (18.25) | 0.954 | 29.84 (28.16) | 25.05 (15.15) | 0.831 |
γ-GGT (U/L) | 66.22 (159.76) | 60.37 (88.60) | 0.378 | 97.19 (174.69) | 48.43 (72.81) | 0.067 |
ALP (U/L) | 115.02 (109.27) | 114.35 (67.34) | 0.216 | 116.33 (66.18) | 113.84 (85.98) | 0.651 |
TBIL (µmol/L) | 14.47 (9.57) | 14.44 (8.10) | 0.584 | 14.56 (9.70) | 14.40 (8.04) | 0.350 |
DBIL (µmol/L) | 3.69 (4.51) | 3.18 (2.43) | 0.476 | 3.49 (3.51) | 3.26 (3.00) | 0.627 |
IDBIL (µmol/L) | 10.79 (5.90) | 11.26 (6.19) | 0.554 | 11.08 (6.65) | 11.15 (5.90) | 0.438 |
TP (g/L) | 70.80 (7.83) | 68.31 (7.55) | 0.077 | 69.42 (7.63) | 68.84 (7.74) | 0.798 |
ALB (g/L) | 39.45 (4.70) | 38.61 (6.41) | 0.189 | 37.44 (4.50) | 39.38 (6.40) | 0.053 |
GLOB (g/L) | 31.30 (4.86) | 30.15 (5.00) | 0.184 | 31.93 (4.76) | 29.91 (4.96) | 0.047 |
PALB (g/L) | 200.44 (66.25) | 210.51 (65.47) | 0.640 | 182.16 (59.81) | 217.55 (65.33) | 0.010 |
Urea (mmol/L) | 5.75 (1.89) | 5.94 (1.63) | 0.501 | 6.31 (1.98) | 5.73 (1.56) | 0.182 |
CREA (µmol/L) | 72.00 (15.17) | 79.40 (16.50) | 0.013 | 78.78 (15.45) | 76.78 (16.83) | 0.375 |
UA (µmol/L) | 297.28 (88.63) | 316.28 (92.69) | 0.169 | 318.66 (92.09) | 308.04 (91.78) | 0.636 |
LDH (U/L) | 229.03 (204.48) | 233.55 (213.03) | 0.836 | 301.75 (274.39) | 205.52 (173.55) | 0.012 |
WBC (109/L) | 7.28 (3.82) | 7.59 (5.32) | 0.769 | 7.58 (3.60) | 7.48 (5.39) | 0.280 |
NEU (109/L) | 4.91 (3.57) | 4.72 (2.17) | 0.658 | 5.26 (3.36) | 4.59 (2.26) | 0.208 |
Lym (109/L) | 1.69 (0.58) | 1.60 (0.56) | 0.476 | 1.57 (0.53) | 1.65 (0.58) | 0.493 |
Mono (109/L) | 0.47 (0.22) | 0.53 (0.21) | 0.150 | 0.55 (0.18) | 0.49 (0.22) | 0.113 |
Eosi (109/L) | 0.12 (0.13) | 0.13 (0.11) | 0.173 | 0.13 (0.10) | 0.12 (0.12) | 0.364 |
Baso (109/L) | 0.03 (0.02) | 0.02 (0.01) | 0.145 | 0.03 (0.02) | 0.02 (0.01) | 0.276 |
Hb (g/L) | 124.03 (21.17) | 126.69 (27.63) | 0.575 | 121.03 (30.31) | 127.85 (23.97) | 0.245 |
RBC (1012/L) | 4.19 (0.66) | 4.45 (0.73) | 0.103 | 4.26 (0.80) | 4.42 (0.68) | 0.363 |
Plt (109/L) | 255.41 (98.83) | 256.23 (91.47) | 0.967 | 279.75 (110.41) | 246.84 (84.53) | 0.213 |
Fbg (g/L) | 3.67 (0.98) | 4.04 (2.78) | 0.902 | 4.78 (4.13) | 3.61 (1.14) | 0.051 |
DDi (mg/L) | 1.54 (2.90) | 1.28 (2.14) | 0.135 | 1.83 (3.18) | 1.17 (1.96) | 0.002 |
- Citation: Deng GM, Song HB, Du ZZ, Xue YW, Song HJ, Li YZ. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor. World J Gastroenterol 2024; 30(8): 863-880
- URL: https://www.wjgnet.com/1007-9327/full/v30/i8/863.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i8.863